References
- Fabunmi R. P., Sukhova G. K., Sugiyama S., Libby P. Expression of tissue inhibitor of metalloproteinases‐3 in human atheroma and regulation in lesion‐associated cells: a potential protective mechanism in plaque stability. Circ Res 1998; 83: 270–8
- Falk E., Shah P. K., Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71
- Shah P. K., Falk E., Badimon J. J., Fernandez‐Ortiz A., Mailhac A., Villareal‐Levy G., et al. Human monocyte‐derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix‐degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565–9
- Newby A. C., Southgate K. M., Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 1994; 89(Suppl 1)59–70
- Brown D. L., Hibbs M. S., Kearney M., Loushin C., Isner J. M. Identification of 92‐kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2125–31
- Nikkari S. T., O'Brien K. D., Ferguson M., Hatsukami T., Welgus H. G., Alpers C. E., et al. Interstitial collagenase (MMP‐1) expression in human carotid atherosclerosis. Circulation 1995; 92: 1393–8
- Henney A. M., Wakeley P. R., Davies M. J., Foster K., Hembry R., Murphy G., et al. Localisation of stromelysin gene expression in atherosclerotic plaques by in situ hybridisation. Proc Natl Acad Sci USA 1991; 88: 8154–8
- Galis Z. S., Sukhova G. K., Lark M. W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–503
- Zaltsman A. B., Newby A. C. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. Atherosclerosis 1997; 130: 61–70
- Birkedal‐Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal‐Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197–250
- Pauly R. R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994; 75: 41–54
- Huhtala P., Tuuttila A., Chow L. T., Lohi J., Keski‐Oja J., Tryggvason K. Complete structure of the human gene for 92‐kDa type IV collagenase. Divergent regulation of expression for the 92‐ and 72‐kilodalton enzyme genes in HT‐1080 cells. J Biol Chem 1991; 266: 16485–90
- Zhang B., Ye S., Herrmann S. M., Eriksson P., de Maat M., Evans A., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999; 99: 1788–94
- Fuster V., Badimon L., Badimon J. J., Chesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. I. N Engl J Med 1992; 326: 242–50
- Davies M. J. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J 1995; 16(Suppl L)3–7
- Wang J., Warzecha D., Wilcken D., Wang X. L. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci 2001; 101: 87–92
- Cho H. J., Chae I. H., Park K. W., Ju J. R., Oh S., Lee M. M., et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet 2002; 47: 88–91
- Gardemann A., Philipp M., Hess P., Katz N., Tillmanns H., Haberbosch W. Paraoxonase Leu‐Met54 and Gln‐Arg191 gene polymorphisms and the risk of coronary heart disease. Atherosclerosis 2000; 152: 421–31
- Rose D. A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27: 645–8
- Gensini G. G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606
- Gardemann A., Schwartz O., Haberbosch W., Katz N., Weiß T., Tillmanns H., et al. Positive association of the ß fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost 1997; 77: 1120–6